Lantern Pharma Advances AI-Driven Drug Discovery Strategy
DALLAS, Aug. 14, 2026 Lantern Pharma Inc. is strengthening its position at the intersection of artificial intelligence and precision...
TechBio
Advertisement
Evaxion AI Platform Drives Next-Gen Vaccine Development
COPENHAGEN, Denmark, August 14, 2026 Evaxion A/S (NASDAQ: EVAX) is preparing to provide a business update and second-quarter 2026...
Aureka Launches OpenDDE to Advance AI Drug Discovery
LAGUNA HILLS, California & SHANGHAI, China, July 6, 2026 Aureka, an AI TechBio company developing next-generation infrastructure for AI-driven...
Evaxion to Present EVX-V1 CMV Vaccine Preclinical Data
COPENHAGEN, Denmark, July 1, 2026 Evaxion A/S announced that it will present new preclinical data for its investigational cytomegalovirus...
Harbour BioMed and BioMap Unveil AI-Powered MegaStream TechBio Platform
CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SHANGHAI, China, June 15, 2026 Harbour BioMed and BioMap have announced a long-term strategic...
Advertisement
